Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindications to Anticoagulation Therapy
Marina Ureña(Montreal Heart Institute), Réda Ibrahim(Université de Montréal), Mélanie Freeman(St. Paul's Hospital), Xavier Freixa(Montreal Heart Institute), John G. Webb(St. Paul's Hospital), Josep Rodés‐Cabau(Institut universitaire de cardiologie et de pneumologie de Québec), Jean Champagne(Université Laval), Jacqueline Saw(University of British Columbia), Jean-François Marquis(Ottawa Heart Institute), Mark Osten(University of Toronto), Albert W. Chan(Royal Columbian Hospital), Eric Horlick(University of Toronto)
Cited by 272
Related Papers
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
|European Heart Journal|2011|1.2k
Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical Risk
|Journal of the American College of Cardiology|2010|973
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
|New England Journal of Medicine|2013|918
Frailty in Older Adults Undergoing Aortic Valve Replacement
|Journal of the American College of Cardiology|2017|785